Recurring Fatigue After Biologic Administration: Patient-Reported Data from the Dutch Biologic Monitor.

Jette A van LintNaomi T JessurunSander W TasHarald E VonkemanMartijn B A van DoornFrank HoentjenMichael T NurmohamedEugene P van PuijenbroekBart J F van den Bemt

Published in: BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy (2023)

IMID patients may experience fatigue as a postdosing effect of biologics.

Keyphrases

patient reported
rheumatoid arthritis
end stage renal disease
newly diagnosed
ejection fraction
sleep quality
peritoneal dialysis
electronic health record
physical activity
artificial intelligence
patient reported outcomes